150 related articles for article (PubMed ID: 12031872)
1. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Heimbold I; Drews A; Kretzschmar M; Varnäs K; Hall H; Halldin C; Syhre R; Kraus W; Pietzsch HJ; Seifert S; Brust P; Johannsen B
Nucl Med Biol; 2002 May; 29(4):375-87. PubMed ID: 12031872
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Drews A; Pietzsch HJ; Syhre R; Seifert S; Varnäs K; Hall H; Halldin C; Kraus W; Karlsson P; Johnsson C; Spies H; Johannsen B
Nucl Med Biol; 2002 May; 29(4):389-98. PubMed ID: 12031873
[TBL] [Abstract][Full Text] [Related]
3. A novel technetium-99m radioligand for the 5-HT(1A) receptor derived from desmethyl-WAY-100635 (DWAY).
Heimbold I; Drews A; Syhre R; Kretzschmar M; Pietzsch HJ; Johannsen B
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):82-7. PubMed ID: 11807611
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor.
Pietzsch HJ; Scheunemann M; Kretzschmar M; Elz S; Pertz HH; Seifert S; Brust P; Spies H; Syhre R; Johannsen B
Nucl Med Biol; 1999 Nov; 26(8):865-75. PubMed ID: 10708299
[TBL] [Abstract][Full Text] [Related]
5. Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Tsoukalas Ch; Nikoladou L; Drossopoulou G; Dalla C; Pelecanou M; Papadopoulou-Daifotis Z; Papadopoulos M; Chiotellis E
Nucl Med Biol; 2002 Nov; 29(8):825-32. PubMed ID: 12453592
[TBL] [Abstract][Full Text] [Related]
6. Preparation and biodistribution of 1-((2-methoxyphenyl) piperazine)ferrocenecarboxamide labeled with technetium-99m as a potential brain receptor imaging agent.
Saied NM; Mejri N; El Aissi R; Benoist E; Saidi M
Eur J Med Chem; 2015 Jun; 97():280-8. PubMed ID: 25993108
[TBL] [Abstract][Full Text] [Related]
7. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterization of p-[(18)F]MPPF, a fluoro analog of WAY-100635 for visualization of 5-HT(1a) receptors.
Ginovart N; Hassoun W; Le Bars D; Weissmann D; Leviel V
Synapse; 2000 Mar; 35(3):192-200. PubMed ID: 10657026
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
[TBL] [Abstract][Full Text] [Related]
11. Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents.
Tsoukalas C; Pirmettis I; Patsis G; Pelecanou M; Bodo K; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
J Inorg Biochem; 2003 Jan; 93(3-4):213-20. PubMed ID: 12576284
[TBL] [Abstract][Full Text] [Related]
12. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Maina T; Pelecanou M; Nikolopoulou A; Chiotellis E; Raptopoulou CP; Vlahos AT; Terzis A; Papadopoulos M; Chiotellis E
J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
[TBL] [Abstract][Full Text] [Related]
13. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example.
Bolzati C; Salvarese N; Carta D; Refosco F; Dolmella A; Pietzsch HJ; Bergmann R; Bandoli G
J Biol Inorg Chem; 2011 Jan; 16(1):137-55. PubMed ID: 20924624
[TBL] [Abstract][Full Text] [Related]
15. Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain.
Castro ME; Harrison PJ; Pazos A; Sharp T
J Neurochem; 2000 Aug; 75(2):755-62. PubMed ID: 10899952
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
[TBL] [Abstract][Full Text] [Related]
18. Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents.
León A; Rey A; Mallo L; Pirmettis I; Papadopoulos M; León E; Pagano M; Manta E; Incerti M; Raptopoulou C; Terzis A; Chiotellis E
Nucl Med Biol; 2002 Feb; 29(2):217-26. PubMed ID: 11823127
[TBL] [Abstract][Full Text] [Related]
19. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
20. Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
Peglion JL; Goument B; Despaux N; Charlot V; Giraud H; Nisole C; Newman-Tancredi A; Dekeyne A; Bertrand M; Genissel P; Millan MJ
J Med Chem; 2002 Jan; 45(1):165-76. PubMed ID: 11754589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
